Clinical trials in malignant pleural mesothelioma in Australasia.
Australasia has a strong record in clinical trials in malignant pleural mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment.
Nowak
Anna K
AK
Department of Medical Oncology, University of Western Australia, 4th Floor, G Block, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia. anowak@cyllene.uwa.edu.au
D000970:Antineoplastic Agents / Q000627:therapeutic use; D044362:Australasia; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008654:Mesothelioma / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D011237:Predictive Value of Tests; D011788:Quality of Life
D000970:Antineoplastic Agents